23andMe, DNA and Regeneron
Digest more
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.
The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.
4h
Daily Voice on MSNWestchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA DataRegeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.
Your 23andMe data is getting a new owner — so what are your options moving forward? The DNA testing company announced on Monday that its assets are being acquired by Regeneron Pharmaceuticals. The sale renewed concerns from some customers online about their data and how its new owner plans to use it.